Season 2 E19: David Wood on substance regulation in the Canada vs. US, psychedelics access for end-of-life distress, and leadership

Meet David Wood, David has been on a mission to broaden regulated access to psychedelics. He is the Chief Legal Officer and General Counsel at Psygen, a Canadian company manufacturing pharmaceutical-grade psychedelics for clinicians and researchers. David also runs R-Group Legal where he provides legal support for a small number of operators in the cannabis industry and the psychedelic space. We talk about substance regulation in Canada versus the US. We cover the special access program avail...